RA CAPITAL MANAGEMENT, L.P.
10% Owner; Director; Director, 10% Owner · 48 filings · Latest: Jun 29, 2026
Acrivon Therapeutics, Inc.
Acumen Pharmaceuticals, Inc.
Adicet Bio, Inc.
ARS Pharmaceuticals, Inc.
Artiva Biotherapeutics, Inc.
Bicara Therapeutics Inc.
Climb Bio, Inc.
Evommune, Inc.
Hemab Therapeutics Holdings, Inc.
Janux Therapeutics, Inc.
LENZ Therapeutics, Inc.
Mineralys Therapeutics, Inc.
Nkarta, Inc.
Parabilis Medicines, Inc.
PepGen Inc.
Prelude Therapeutics Inc
Septerna, Inc.
Sionna Therapeutics, Inc.
SpyGlass Pharma, Inc.
Tyra Biosciences, Inc.
Vor Biopharma Inc.
Wave Life Sciences Ltd.
Werewolf Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
COAG | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | May 12, 2026 | Purchase | $24.90 | 6,387 | $159.0K | 6,372,170 | |
ARTV | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | May 11, 2026 | Purchase | $11.52 | 6,510,416 | $75.0M | 15,203,995 | |
HOWL | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | May 12, 2026 | Sale | $0.64 | 101,151 | $64.7K | 406,282 | |
HOWL | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | May 11, 2026 | Sale | $0.67 | 87,490 | $58.6K | 413,001 | |
HOWL | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | May 8, 2026 | Sale | $0.71 | 376,526 | $267.3K | 418,813 | |
COAG | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | May 11, 2026 | Purchase | $24.81 | 39,869 | $989.2K | 6,365,783 | |
COAG | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | May 8, 2026 | Purchase | $24.98 | 1,483 | $37.0K | 6,325,914 | |
COAG | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | May 7, 2026 | Purchase | $24.46 | 9,906 | $242.3K | 6,324,431 | |
COAG | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | May 6, 2026 | Purchase | $24.60 | 68,018 | $1.7M | 6,314,525 | |
COAG | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | May 5, 2026 | Purchase | $24.63 | 97,411 | $2.4M | 6,246,507 | |
COAG | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | May 4, 2026 | Purchase | $18.00 | 2,675,000 | $48.1M | 354,938 | |
VOR | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Apr 22, 2026 | Sale | $15.77 | 165,150 | $2.6M | 2,402,095 | |
VOR | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Apr 20, 2026 | Sale | $15.77 | 171,963 | $2.7M | 2,567,245 | |
VOR | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Apr 17, 2026 | Sale | $16.28 | 458,411 | $7.5M | 2,739,208 | |
VOR | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Apr 15, 2026 | Sale | $16.01 | 53,644 | $858.8K | 3,197,619 | |
VOR | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Apr 14, 2026 | Sale | $15.97 | 153,735 | $2.5M | 3,251,263 | |
VOR | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Apr 13, 2026 | Sale | $16.15 | 530,610 | $8.6M | 3,404,998 | |
ACET | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Feb 20, 2026 | Purchase | $7.27 | 74,751 | $543.4K | 1,182,624 | |
ACET | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Feb 19, 2026 | Purchase | $7.21 | 74,268 | $535.5K | 1,107,873 | |
ACET | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Feb 18, 2026 | Purchase | $7.04 | 74,577 | $525.0K | 1,033,605 |